ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.163,52
-0,41%
S&P 500
5.464,62
-0,16%
Dow Jones
39.150,33
0,04%
Euro vs US Dollar
1,06925
0,00%
Bitcoin
64.415,11
0,26%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. USOTC
  6. Merck KGaA (PK) (MKKGY)

  7. Merck KGaA (PK) (MKKGY) News

MKKGY

Merck KGaA (PK) (MKKGY)

Merck KGaA (PK)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:USOTC:MKKGY
DatumZeitQuelleÜberschriftSymbolFirma
06/12/202314h20Dow Jones NewsTrending: Merck's Multiple Sclerosis Drug Misses Expectations in Late-Stage TrialsUSOTC:MKKGYMerck KGaA (PK)
06/12/202311h14Dow Jones NewsMerck Shares Slump After Multiple Sclerosis Drug Fails in Late-Stage TrialsUSOTC:MKKGYMerck KGaA (PK)
06/12/202307h37Dow Jones NewsMerck MS Drug Fails to Meet Target of Late-Stage TrialsUSOTC:MKKGYMerck KGaA (PK)
04/12/202315h09Dow Jones NewsMerck to Pay at Least $70 Million for Rights to Abbisko Joint-Tumor DrugUSOTC:MKKGYMerck KGaA (PK)
09/11/202307h54Dow Jones NewsMerck KGaA Sees Earnings, Sales at Lower Half of Outlook RangesUSOTC:MKKGYMerck KGaA (PK)
06/11/202312h20Dow Jones NewsMerck KGaA Weighs Job Cuts at Electronics Division on Market DownturnUSOTC:MKKGYMerck KGaA (PK)
30/10/202309h59Dow Jones NewsMerck KGaA Enters Partnership With China's Hengrui for Up to $1.5 BillionUSOTC:MKKGYMerck KGaA (PK)
19/10/202310h22Dow Jones NewsMerck KGaA Shares Jump on Expected Return to Sales Growth in 2024USOTC:MKKGYMerck KGaA (PK)
19/10/202308h50Dow Jones NewsMerck KGaA Sees Return to Organic Sales Growth Next YearUSOTC:MKKGYMerck KGaA (PK)
20/09/202312h47Dow Jones NewsExscientia Shares Rally Premarket on Lucrative Merck DealUSOTC:MKKGYMerck KGaA (PK)
20/09/202308h05Dow Jones NewsMerck KGaA Enters Deal With BenevolentAI, Exscientia for AI-Based Drug DiscoveryUSOTC:MKKGYMerck KGaA (PK)
03/08/202307h55Dow Jones NewsMerck KGaA Cuts 2023 Outlook on Inventory, Semiconductor WoesUSOTC:MKKGYMerck KGaA (PK)
11/05/202307h46Dow Jones NewsMerck KgaA 1Q Earnings Hit by Lower Covid-19 Demand, Decline at Display SolutionsUSOTC:MKKGYMerck KGaA (PK)
08/05/202313h49Dow Jones NewsMerck KGaA Appoints Helene von Roeder as New CFOUSOTC:MKKGYMerck KGaA (PK)
13/04/202315h41Dow Jones NewsMerck KGaA Planning Sale of Surface Solutions Business, WirtschaftsWoche ReportsUSOTC:MKKGYMerck KGaA (PK)
12/04/202312h51Dow Jones NewsMerck KGaA to Invest $327 Million in Pennsylvania Site ExpansionUSOTC:MKKGYMerck KGaA (PK)
12/04/202309h54Dow Jones NewsMerck KGaA Shares Fall After US Puts Hold on New Patients in MS Drug TrialUSOTC:MKKGYMerck KGaA (PK)
02/03/202310h50Dow Jones NewsMerck KGaA Shares Fall After Warning of Challenges AheadUSOTC:MKKGYMerck KGaA (PK)
02/03/202307h44Dow Jones NewsMerck KGaA Sees Challenging 2023 After Rises in 2022 Earnings, SalesUSOTC:MKKGYMerck KGaA (PK)
22/11/202201h18Dow Jones NewsADRs End Mostly Lower, Naspers and Merck Trade ActivelyUSOTC:MKKGYMerck KGaA (PK)
21/11/202214h03Dow Jones NewsMerck KGaA Says It Plans One New Drug Launch Every One and a Half YearsUSOTC:MKKGYMerck KGaA (PK)
10/11/202208h04Dow Jones NewsMerck KGaA 3Q Sales, Earnings Rose; Fine-Tunes 2022 OutlookUSOTC:MKKGYMerck KGaA (PK)
19/10/202215h58Dow Jones NewsMerck KGaA's French Subsidiary Indicted in France Over Drug Formulation ChangeUSOTC:MKKGYMerck KGaA (PK)
19/10/202211h32Dow Jones NewsMerck KGaA's French Unit Under Further Investigations, AFP ReportsUSOTC:MKKGYMerck KGaA (PK)
06/10/202208h55Dow Jones NewsMerck KGaA Backs Mid-Term Targets; Plans Acquisitions as of 2023USOTC:MKKGYMerck KGaA (PK)
04/08/202208h06Dow Jones NewsMerck KGaA Earnings, Sales Grew in 2QUSOTC:MKKGYMerck KGaA (PK)
03/06/202216h21Dow Jones NewsMerck KGaA Discontinues Phase 2 Trial of Berzosertib in Combination With TopotecanUSOTC:MKKGYMerck KGaA (PK)
02/06/202218h38Dow Jones NewsProxygen Teams With Merck KGaA to Develop Molecular Glue DegradersUSOTC:MKKGYMerck KGaA (PK)
23/05/202211h53Dow Jones NewsMerck KGaA to Invest Around $465 Million to Expand Operations in IrelandUSOTC:MKKGYMerck KGaA (PK)
12/05/202207h31Dow Jones NewsMerck KGaA Expects Higher Profitability, Sales in 2022 After 1Q Earnings RiseUSOTC:MKKGYMerck KGaA (PK)
 Showing the most relevant articles for your search:USOTC:MKKGY

Kürzlich von Ihnen besucht

USOTC
IDDWF
Indutrade AB (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten